This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/524336-south-korea-trial-astrazeneca-pfizer-covid-vaccines/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| Mix and match your jabs: South Korea kicks off trial mixing AstraZeneca and Pfizer Covid-19 vaccines | Mix and match your jabs: South Korea kicks off trial mixing AstraZeneca and Pfizer Covid-19 vaccines |
| (4 months later) | |
| South Korea has announced that it will begin a clinical trial into mixing doses of AstraZeneca and Pfizer Covid-19 vaccines to speed up inoculation campaigns amid delays caused by production issues and safety fears. | South Korea has announced that it will begin a clinical trial into mixing doses of AstraZeneca and Pfizer Covid-19 vaccines to speed up inoculation campaigns amid delays caused by production issues and safety fears. |
| The new trial will include 500 military personnel who have received one dose of the AstraZeneca vaccine, examining their immune response after being given a second dose of the Pfizer jab. A timeline for the study has not been outlined but the selection of participants is expected to be diverse, according to a South Korean health official. | The new trial will include 500 military personnel who have received one dose of the AstraZeneca vaccine, examining their immune response after being given a second dose of the Pfizer jab. A timeline for the study has not been outlined but the selection of participants is expected to be diverse, according to a South Korean health official. |
| Authorities in South Korea were one of several nations that suspended the use of the AstraZeneca vaccine temporarily over concerns about blood clots in recipients of the jab. However, after a review by the European Medicines Agency and other regulatory health officials, South Korea recommenced use of AstraZeneca doses for all over 30s. | Authorities in South Korea were one of several nations that suspended the use of the AstraZeneca vaccine temporarily over concerns about blood clots in recipients of the jab. However, after a review by the European Medicines Agency and other regulatory health officials, South Korea recommenced use of AstraZeneca doses for all over 30s. |
| The South Korean vaccination campaign has, so far, administered 4,674,151 doses of a Covid jab in the country of 51.7 million. | The South Korean vaccination campaign has, so far, administered 4,674,151 doses of a Covid jab in the country of 51.7 million. |
| The rollout has been delayed by global vaccine shortages and delays to shipments, limiting the country’s chances of meeting its goal of herd immunity by November. | The rollout has been delayed by global vaccine shortages and delays to shipments, limiting the country’s chances of meeting its goal of herd immunity by November. |
| South Korea is the latest in a string of countries to begin trials mixing Covid vaccines to explore ways of speeding up vaccination campaigns domestically and globally. Earlier in May, the CombivacS study conducted among 676 participants in Spain produced positive results that indicate it is safe and effective to combine the AstraZeneca and Pfizer jabs. | South Korea is the latest in a string of countries to begin trials mixing Covid vaccines to explore ways of speeding up vaccination campaigns domestically and globally. Earlier in May, the CombivacS study conducted among 676 participants in Spain produced positive results that indicate it is safe and effective to combine the AstraZeneca and Pfizer jabs. |
| France and Germany have previously recommended mixing two vaccines despite not having completed the clinical trial data on the safety and effectiveness of doing so. A number of European countries and Australia are in the process of considering the commencement of their own ‘mix and match’ vaccine trials, with Australian Health Secretary Brendan Murphy stating that there is “no good scientific reason” not to get two different shots. | France and Germany have previously recommended mixing two vaccines despite not having completed the clinical trial data on the safety and effectiveness of doing so. A number of European countries and Australia are in the process of considering the commencement of their own ‘mix and match’ vaccine trials, with Australian Health Secretary Brendan Murphy stating that there is “no good scientific reason” not to get two different shots. |
| Since the start of the pandemic, South Korea has recorded 134,117 confirmed cases of Covid-19 and 1,916 deaths from the virus, according to data provided to the World Health Organization as of May 20. | Since the start of the pandemic, South Korea has recorded 134,117 confirmed cases of Covid-19 and 1,916 deaths from the virus, according to data provided to the World Health Organization as of May 20. |
| If you like this story, share it with a friend! | If you like this story, share it with a friend! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |